September 30, 2022 by Chain Drug Review
CHPA, Scott Melville
Leading Headlines, Supplier News
WASHINGTON – Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, on Friday released the below statement following congressional passage of a short-term spending package to fund the Federal Government through Dec. 16. Included in this Continuing Resolution is legislation to reauthorize the U.S. Food and Drug Administration’s (FDA) user fee programs for prescription
September 12, 2022 by Chain Drug Review
CHPA, Scott Melville
Leading Headlines, Supplier News
WASHINGTON, DC) – Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, today released the following statement in response to the U.S. Food and Drug Administration’s (FDA) announcement of a joint meeting between its Advisory Committees on Nonprescription Drugs and Obstetrics and Reproductive and Urologic Drugs. The meeting has been scheduled for Nov. 18,
June 27, 2022 by Chain Drug Review
CHPA’s president and CEO, Scott Melville, today released the following statement in response to the FDA releasing a proposed rule on "Nonprescription Drug Product with an Additional Condition for Nonprescription Use" (ACNU):
Leading Headlines, Pharmacy, Supplier News
WASHINGTON — CHPA’s president and CEO, Scott Melville, today released the following statement in response to the FDA releasing a proposed rule on “Nonprescription Drug Product with an Additional Condition for Nonprescription Use” (ACNU): “CHPA is pleased the FDA has issued this long-awaited proposed rule. Prescription to over-the-counter switches for certain pharmaceutical ingredients (“Rx-to-OTC switch”) have
September 17, 2021 by Chain Drug Review
CHPA, Scott Melville
Leading Headlines, Supplier News
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement from Scott Melville, president and CEO, upon the introduction of H.R. 5214, the Dietary Supplements Access Act, by Representatives John Curtis (R, Utah) and Josh Gottheimer (D, N.J.): “CHPA applauds Representatives Curtis and Gottheimer for introducing bipartisan legislation that would make dietary supplements
February 5, 2021 by Chain Drug Review
CBD bill, CHPA, Scott Melville
Leading Headlines, Supplier News
WASHINGTON— Scott Melville, president and CEO of the Consumer Healthcare Products Association (CHPA) applauded the introduction of the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, that was introduced on Thursday. CHPA has also become part of a larger coalition of organizations who support the bill. “We’re encouraged that this legislation
December 11, 2020 by Chain Drug Review
CHPA, Scott Melville
Leading Headlines, Supplier News
WASHINGTON — The Consumer Healthcare Products Association (CHPA) continued its rebranding effort which began earlier this year with the recent launch of a new flagship website, www.CHPA.org. The association’s new interactive site includes expanded information and resources for the personal healthcare industry — which includes over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. The
November 19, 2020 by Chain Drug Review
Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News
WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced the election of two new members to the CHPA Board of Directors during the association’s virtual November meeting. Newly elected CHPA board members include: Tim Grannan, president, Blistex Inc. Don Kerrigan, president, North America, The Nature’s Bounty Co. Kerrigan was also elected to serve on the
October 1, 2020 by Chain Drug Review
CHPA, Nature's Bounty, Paul Sturman, Scott Melville
Leading Headlines, Supplier News
WASHINGTON – The Nature’s Bounty Co., a global leader in health and wellness, has joined the Consumer Healthcare Products Association (CHPA) as its newest member. Nearly half of CHPA’s current members manufacture or market dietary supplements in addition to either over-the-counter (O-T-C) and/or consumer medical device products, but The Nature’s Bounty Co. – a manufacturer
June 15, 2020 by Jeffrey Woldt
Chain Drug Review's Video Forum, CHPA, enacted O-T-C monograph reform, Scott Melville
Featured Articles, Leading Headlines, Videos
The latest installment in our Video Forum features Scott Melville, president and chief executive officer of the Consumer Healthcare Products Association. In addition to the rebranding of CHPA, Melville talks about what recently enacted O-T-C monograph reform means for the category, and the increasingly important part that nonprescription products are playing in health care.
June 1, 2020 by Jeffrey Woldt
CHPA, Scott Melville
June 1, 2020, Leading Headlines, Supplier News
WASHINGTON — Coming off one of the most significant public policy victories in its 139-year history, the Consumer Healthcare Products Association (CHPA) is updating its brand image and revamping its structure to better reflect the expanding scope of the over-the-counter health care sector. “We asked our members what we want to be, who we want
April 14, 2020 by Chain Drug Review
Paul Gama, Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News
WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced on Tuesday the appointment of Paul Gama as the new chair of the CHPA board of directors. Gama was elected on April 13, 2020, along with other new board members, at CHPA’s annual membership meeting conducted, for the first time ever, in a virtual forum online.
April 9, 2020 by Chain Drug Review
CHPA, COVID-19, O-T-Cs, Scott Melville
Leading Headlines
WASHINGTON— Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, issued the following statement upon final passage of the CARES Act, which among its many sections includes provisions to update and modernize the regulatory system overseeing most over-the-counter (O-T-C) medicines and to restore O-T-C eligibility under tax-preferred HSA and FSA accounts. “During this unprecedented
March 9, 2020 by Chain Drug Review
Dr. John Troup, Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News
WASHINGTON — The Consumer Healthcare Products Association (CHPA) announced the appointment of Dr. John Troup as vice president for scientific affairs and dietary supplements, a brand-new position within CHPA. Dr. Troup has wide-ranging experience in the health, nutrition and dietary supplements sectors, including extensive work in clinical and product development, as well as regulatory affairs.
January 13, 2020 by Scott Melville
CHPA, Scott Melville
January 6, 2020, Opinion
Welcome to 2020, where, more than ever, patients and caregivers are taking control of their health care decisions and an increasing array of consumer health care products is helping them get well, stay healthy, treat minor ailments and even manage some chronic conditions. The marketplace is evolving before our eyes, including the manufacturers, who are
